Equity Profile

PBH

Prestige Consumer Healthcare Inc.

Health CarePharmaceuticals$2.2B

May13Wed

Post-Earnings Recap

ReportedQ4-2026After Close4:30 PM EDT

Prestige Consumer Healthcare Inc. Misses on EPS, Stock Up 2.78%

Metric	Actual	Expected	Surprise
EPS	$1.23	$1.39	-11.70%
Revenue	N/A	$295M	N/A

management commentary, guidance changes, and full analysis available with Pro.

Prestige Consumer Healthcare Inc. Misses on EPS, Stock Up 2.78%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.23	$1.39	-11.70%
Revenue	N/A	$295M	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Prestige Consumer Healthcare's earnings report showed a significant miss on EPS expectations, which could raise concerns among investors. However, the stock reacted positively, increasing by 2.78%, possibly due to market factors unrelated to earnings. The lack of revenue data and management commentary leaves some uncertainty about the company's performance outlook.

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceuticals and consumer health products....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance relative to expectations.

$1.39

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$295M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceuticals and consumer health products. With a market cap of $2 billion, the company plays a significant role in the consumer health market, which has seen increased demand due to heightened health awareness among consumers.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In Q3-2026, Prestige reported an EPS of $1.14, slightly below the estimate of $1.16, resulting in a stock decline of 2.21% the following day. The company has faced challenges in meeting earnings expectations recently.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Prestige to report an EPS of $1.39 and revenue of $295 million for Q4-2026, reflecting cautious optimism as the company seeks to rebound from previous misses.

Bull Case

If Prestige can exceed EPS expectations, it may indicate a strong recovery in sales and improved operational efficiency, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its growth trajectory and market competitiveness, leading to further stock declines.

Key Metrics to Watch

EPS

$1.39

Earnings per share is a key indicator of the company's profitability and performance relative to expectations.

Revenue

$295M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.39?

A beat on EPS could signal a turnaround in the company's performance and boost investor confidence.

What factors contributed to the revenue forecast of $295 million?

Understanding the drivers behind revenue expectations will help assess the company's market position and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the potential for a strong rebound in sales, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

The stock has shown resilience in past quarters, often bouncing back after initial misses.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

Recent trends in consumer health spending may not be fully reflected in analyst forecasts.

Key Risk

If revenue exceeds $300 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report is critical as it follows a series of misses, and investors are keen to see if the company can regain momentum.

Bull Confirmed If

An EPS of $1.40 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.38 would support the bear case, raising concerns about the company's ability to grow.

Pre-Earnings Positioning

Options Market

Implied Move

±14.43%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±14.4% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

42.1%

Calls (4K)P/C Ratio: 0.15Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 2 of 3 (67%)

This setup has occurred 30 times across Health Care in the last 2 years. 2 of 3 (67%) reversed within 5 days — this setup typically fades. The average absolute 1-day move is 3.7%, with a raw directional average of -2.2% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around 5.17%, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react moderately, reflecting ongoing caution among investors.

Miss

A miss could lead to a decline of approximately 3.63%, further eroding investor confidence in the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on sales growth from new product launches.
2Any commentary on market share trends in the consumer health sector.
3Insights into cost management and operational efficiencies.
4Updates on consumer demand trends and their impact on future guidance.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ORIX Corporation

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceuticals and consumer health products....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance relative to expectations.

$1.39

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$295M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Prestige to report an EPS of $1.39 and revenue of $295 million for Q4-2026, reflecting cautious optimism as the company seeks to rebound from previous misses.

Bull Case

If Prestige can exceed EPS expectations, it may indicate a strong recovery in sales and improved operational efficiency, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its growth trajectory and market competitiveness, leading to further stock declines.

Key Metrics to Watch

EPS

$1.39

Earnings per share is a key indicator of the company's profitability and performance relative to expectations.

Revenue

$295M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.39?

A beat on EPS could signal a turnaround in the company's performance and boost investor confidence.

What factors contributed to the revenue forecast of $295 million?

Understanding the drivers behind revenue expectations will help assess the company's market position and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the potential for a strong rebound in sales, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

The stock has shown resilience in past quarters, often bouncing back after initial misses.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

Recent trends in consumer health spending may not be fully reflected in analyst forecasts.

Key Risk

If revenue exceeds $300 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report is critical as it follows a series of misses, and investors are keen to see if the company can regain momentum.

Bull Confirmed If

An EPS of $1.40 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.38 would support the bear case, raising concerns about the company's ability to grow.

Pre-Earnings Positioning

Options Market

Implied Move

±14.43%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±14.4% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

42.1%

Calls (4K)P/C Ratio: 0.15Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 2 of 3 (67%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige beats expectations, history suggests a potential stock increase of around 5.17%, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react moderately, reflecting ongoing caution among investors.

Miss

A miss could lead to a decline of approximately 3.63%, further eroding investor confidence in the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on sales growth from new product launches.
2Any commentary on market share trends in the consumer health sector.
3Insights into cost management and operational efficiencies.
4Updates on consumer demand trends and their impact on future guidance.